Application Nr Approved Date Route Status External Links
ANDA076204 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Moexipril Hydrochloride Tablets Usp Are Indicated For Treatment Of Patients With Hypertension. It May Be Used Alone Or In Combination With Thiazide Diuretics. In Using Moexipril Hydrochloride Tablets Usp, Consideration Should Be Given To The Fact That Another Ace Inhibitor, Captopril, Has Caused Agranulocytosis, Particularly In Patients With Renal Impairment Or Collagen-Vascular Disease. Available Data Are Insufficient To Show That Moexipril Hydrochloride Tablets Usp Do Not Have A Similar Risk (See Warnings ). In Considering Use Of Moexipril Hydrochloride Tablets Usp, It Should Be Noted That In Controlled Trials Ace Inhibitors Have An Effect On Blood Pressure That Is Less In Black Patients Than In Non-Blacks. In Addition, Ace Inhibitors (For Which Adequate Data Are Available) Cause A Higher Rate Of Angioedema In Black Than In Non-Black Patients (See Warnings, Angioedema ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Moexipril Hydrochloride MOEXIPRIL HYDROCHLORIDE ZINC3812306

Comments